Mar 19, 2021, 15:39 PM by

Future Planet Capital has invested in a $168m Series B financing announced today by Vaccitech Ltd.

Mar 19, 2021, 15:39 PM by

Mar 19, 2021, 15:39 PM by

Mar 19, 2021, 15:39 PM by

Mar 19, 2021, 15:39 PM by

THREAD, a technology and service provider enabling decentralized clinical trials (DCTs), today announced the launch of new telehealth features. Building on four years of conducting electronic clinical outcome assessments (eCOA) during telehealth virtual visits, the new features raise the bar in DCT telehealth functionality by adding several unique enhancements to the company’s industry-leading eCOA and telehealth virtual visit solution. New features allow clinical study stakeholders – including sponsors, caregivers, home health professionals and raters – to remotely and safely capture video and/or audio recordings in real time.

Mar 19, 2021, 15:39 PM by

Mar 19, 2021, 15:39 PM by

As the company celebrates its 10th anniversary this year, it is pleased to announce a strong 2020, reporting 1 Trillion won in sales!

Mar 19, 2021, 15:39 PM by

Mar 19, 2021, 15:39 PM by

Notes to editors Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management company is based in Moscow. RDIF has established joint strategic partnerships with leading international co-investors from over 18 countries attracting over $40 bn of capital. Further information can be found at rdif.ru For more information about the Sputnik vaccine please visit sputnikvaccine.com/ Stelis Biopharma Pvt. Ltd. (Stelis) is a vertically integrated biopharmaceutical company. Stelis offers end-to-end state-of-the-art CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. Its operations include R&D, process development, scale-up & end-to-end cGMP manufacturing capabilities from drug substance through drug product in all formats and packaging. Stelis is also developing select follow-on biologic products for global markets in niche and commercially attractive disease categories. Stelis has recently forayed into Vaccine manufacturing with a capability to do multiple vaccine types. Stelis’ state-of-the-art research & development facility and 200,000 sq. ft. fully integrated cGMP manufacturing facility are located in Bengaluru, India. Facilities cater to the development and cGMP manufacturing of biologics and injectables conforming to international standards. For more information visit www.stelis.com Strides, listed on the BSE Limited (532531) and National Stock Exchange of India Limited (STAR), is a global pharmaceutical company headquartered in Bengaluru, India. The Company mainly operates in the regulated markets and has an “in Africa for Africa” strategy along with an institutional business to service donor-funded markets. The Company’s global manufacturing sites are located in India (Chennai, Puducherry and two locations in Bengaluru), Singapore, Italy (Milan), Kenya (Nairobi) and the United States (Florida). The Company focusses on “difficult to manufacture” products that are sold in over 100 countries. Additional information is available at the Company’s website at www.strides.com

Mar 18, 2021, 17:12 PM by User Not Found

Bio-IT World | Illumina has announced that Jay Flatley has decided to step down from the Board of Directors and John W. Thompson will be appointed as the Company’s new Chair of the Board. These changes will be effective as of the Company’s Annual Shareholder Meeting on May 26, 2021.

Mar 18, 2021, 01:00 AM by User Not Found

Bio-IT World | The unprecedented accomplishment that is Moderna’s innovative mRNA Covid-19 vaccine proves—among other things—that a shift has come to life sciences. It’s time to bet on the underdog.

Mar 17, 2021, 01:00 AM by User Not Found

Bio-IT World | For well over a decade now, scientists have been experimenting with “couch potato” drugs that could confer the benefits of exercise without having to flex a muscle. The latest candidate is a small molecule inhibitor impeding the degradation of prostaglandin E2 (PGE2), recently shown to act directly on mature muscle fibers to prevent deleterious molecular changes that arise with aging.

Mar 15, 2021, 14:09 PM by User Not Found

Bio-IT World | Researchers at the University of Sussex have figured out a way to give desktop PCs the same horsepower as supercomputers, which could help democratize research involving large-scale brain simulations.

Mar 12, 2021, 11:19 AM by User Not Found

Bio-IT World | Top COVID-19 news and research stories of the week: new variants will evade antibodies, inconsistencies in the Pfizer-BioNTech vaccine batches, and a new COVID Antibody Epitope Mapping service.

Mar 10, 2021, 10:11 AM by

The MDI Biological Laboratory will collaborate with the Maine Center for Disease Control and Prevention, an office of the state Department of Health and Human Services, on a five-year grant from the federal Centers for Disease Control and Prevention (CDC), to improve access to safe drinking water in Maine.

Mar 10, 2021, 10:11 AM by

Shimmer’s Verisense platform can now measure clinical trial participants’ heart rate, oxygen saturation and emotional responses in addition to their activity and sleep levels.

Mar 10, 2021, 10:11 AM by

Mar 10, 2021, 10:11 AM by

Compugen selects Dotmatics’ cloud-based LIMS and ELN solution to drive efficient drug discovery Agreement marks the first implementation of Dotmatics SaaS technology in Israel, further extending global access

Mar 10, 2021, 10:11 AM by

Integrated DNA Technologies (IDT) has launched its rhAmpSeq™ CRISPR Analysis System, which offers an end-to-end solution for characterizing and quantifying the full array of on- and off-target genome editing events in CRISPR research projects.

Mar 10, 2021, 10:10 AM by

AARDEX Group, the world leader in medication adherence solutions, continues to build up its ecosystem and to bridge GMP to GCP world in Clinical Trials by reinforcing their strategic partnership with Schreiner MediPharm, a global specialist in innovative functional labels and smart packaging solutions for the pharmaceutical industry.